- Home
- EBMT vs SCLX Comparison
EBMT vs SCLX Comparison
Compare EBMT & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBMT
- SCLX
- Stock Information
- Founded
- EBMT 1922
- SCLX 2011
- Country
- EBMT United States
- SCLX United States
- Employees
- EBMT N/A
- SCLX 113
- Industry
- EBMT Major Banks
- SCLX Biotechnology: Pharmaceutical Preparations
- Sector
- EBMT Finance
- SCLX Health Care
- Exchange
- EBMT Nasdaq
- SCLX Nasdaq
- Market Cap
- EBMT 130.6M
- SCLX 81.7M
- IPO Year
- EBMT N/A
- SCLX N/A
- Fundamental
- Price
- EBMT $16.60
- SCLX $0.61
- Analyst Decision
- EBMT
- SCLX Strong Buy
- Analyst Count
- EBMT 0
- SCLX 3
- Target Price
- EBMT N/A
- SCLX $11.33
- AVG Volume (30 Days)
- EBMT 20.6K
- SCLX 184.3K
- Earning Date
- EBMT 10-29-2024
- SCLX 11-26-2024
- Dividend Yield
- EBMT 3.45%
- SCLX N/A
- EPS Growth
- EBMT N/A
- SCLX N/A
- EPS
- EBMT 1.09
- SCLX N/A
- Revenue
- EBMT $80,038,000.00
- SCLX $50,833,000.00
- Revenue This Year
- EBMT N/A
- SCLX $32.77
- Revenue Next Year
- EBMT $8.40
- SCLX $50.71
- P/E Ratio
- EBMT $15.27
- SCLX N/A
- Revenue Growth
- EBMT N/A
- SCLX 9.41
- 52 Week Low
- EBMT $11.63
- SCLX $0.54
- 52 Week High
- EBMT $17.65
- SCLX $2.63
- Technical
- Relative Strength Index (RSI)
- EBMT 51.64
- SCLX 28.71
- Support Level
- EBMT $16.03
- SCLX $0.73
- Resistance Level
- EBMT $17.14
- SCLX $1.14
- Average True Range (ATR)
- EBMT 0.26
- SCLX 0.11
- MACD
- EBMT -0.03
- SCLX -0.04
- Stochastic Oscillator
- EBMT 51.35
- SCLX 11.99
About EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.